RBM20 variants disrupt Ca(2+) handling and metabolism in dilated and non-compaction cardiomyopathy stem cell models.

Rebs S, Sedaghat-Hamedani F, Kayvanpour E, Eberl H, Berečić B, Dudek J, Wagensohner N, Seedorf A, Unsöld JK, Hübscher D, Reich C, Klein T, Doose S, Nikolaev VO, Buchwald T, Wagdi A, Kohlhaas M, Dybkova N, Morais Costa P, Guan K, Hasenfuss G, Rog-Zielinska EA, Sossalla S, Sauer M, Maack C, Tiburcy M, Meder B, Streckfuss-Bömeke K

Open source

DOI
10.1038/s41392-026-02838-7
Published
2026 Jul 14
Container
Signal transduction and targeted therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41392-026-02838-7,
  title = {RBM20 variants disrupt Ca(2+) handling and metabolism in dilated and non-compaction cardiomyopathy stem cell models.},
  author = {Rebs S and Sedaghat-Hamedani F and Kayvanpour E and Eberl H and Berečić B and Dudek J and Wagensohner N and Seedorf A and Unsöld JK and Hübscher D and Reich C and Klein T and Doose S and Nikolaev VO and Buchwald T and Wagdi A and Kohlhaas M and Dybkova N and Morais Costa P and Guan K and Hasenfuss G and Rog-Zielinska EA and Sossalla S and Sauer M and Maack C and Tiburcy M and Meder B and Streckfuss-Bömeke K},
  year = {2026},
  journal = {Signal transduction and targeted therapy},
  doi = {10.1038/s41392-026-02838-7},
  url = {https://doi.org/10.1038/s41392-026-02838-7}
}

RIS

TY  - JOUR
TI  - RBM20 variants disrupt Ca(2+) handling and metabolism in dilated and non-compaction cardiomyopathy stem cell models.
AU  - Rebs S
AU  - Sedaghat-Hamedani F
AU  - Kayvanpour E
AU  - Eberl H
AU  - Berečić B
AU  - Dudek J
AU  - Wagensohner N
AU  - Seedorf A
AU  - Unsöld JK
AU  - Hübscher D
AU  - Reich C
AU  - Klein T
AU  - Doose S
AU  - Nikolaev VO
AU  - Buchwald T
AU  - Wagdi A
AU  - Kohlhaas M
AU  - Dybkova N
AU  - Morais Costa P
AU  - Guan K
AU  - Hasenfuss G
AU  - Rog-Zielinska EA
AU  - Sossalla S
AU  - Sauer M
AU  - Maack C
AU  - Tiburcy M
AU  - Meder B
AU  - Streckfuss-Bömeke K
PY  - 2026
JO  - Signal transduction and targeted therapy
DO  - 10.1038/s41392-026-02838-7
UR  - https://doi.org/10.1038/s41392-026-02838-7
ER  - 

APA

S, R., F, S., E, K., H, E., B, B., J, D., N, W., A, S., JK, U., D, H., C, R., T, K., S, D., VO, N., T, B., A, W., M, K., N, D., P, M. C., K, G., G, H., EA, R., S, S., M, S., C, M., M, T., B, M., & K, S. (2026). RBM20 variants disrupt Ca(2+) handling and metabolism in dilated and non-compaction cardiomyopathy stem cell models.. Signal transduction and targeted therapy. https://doi.org/10.1038/s41392-026-02838-7

Source records